Loading data for TWST — first visit, this takes a few seconds.

Alerta

Twist Bioscience Corporat... (TWST)

NasdaqGS: TWST · Precio en tiempo real · USD

141.38

-11.72 (-7.66%)

Al cierre: Aug 28, 2026, 3:59 PM

141.01

-0.26%

Fuera de horario: 7:51 PM

El precio, las cifras principales y las últimas noticias, en un solo sitio.

-7.66% (1D)

Precio de compra	110.13
Capitalización de mercado	8.87B
Ingresos (TTM)	431.8M
Beneficio neto (TTM)	-136.72M
	2.16
	-2.24
	n/a
	-223.23
P/B (TTM)	19.88
P/S (TTM)	20.53
Fecha de resultados	Nov 16, 2026

Precio de venta	143.08
Volumen	1,377,467
Volumen medio (20D)	1,798,377
Abierto	150.05
Anterior Cerrar	153.10
Rango del día	141.00 - 153.11
Rango de 52 semanas	23.30 - 155.44
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de TWST

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mu...

[Leer más]

Industria Diagnostics & Research

Sector Healthcare

IPO Fecha Oct 31, 2018

Empleados 979

Bolsa de Valores NasdaqGS

Símbolo bursátil TWST

Sitio web https://www.twistbioscience.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Twist Bioscience fueron 376.57M, un aumento de 20.32% en comparación con 312.97M del año anterior. Las ganancias fueron -77.67M, una disminución de -62.79%.

Estados financieros

Sorpresa de resultados

Twist Bioscience ha publicado sus resultados trimestrales en Aug 3, 2026:

Ingresos de $118.38M falla las estimaciones por $0, con 23.24% Crecimiento interanual.
EPS de -0.56 falla las estimaciones por -0.38, con -19.15% Disminución interanual.

Próxima publicación de resultados

Está previsto que Twist Bioscience Corporation publique sus resultados el Nov 16, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

1 semana hace · MT Newswires

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index rising 3.1% a

1 semana hace · Stocktwits

‘Pharma Bro’ Martin Shkreli Slams Anthropic’s Claude Drug-Discovery Claims: ‘This Is Not Impressive Work’

Claude-designed proteins successfully bound to 14 of 15 targets in independent testing by Adaptyv Bio and Twist Bioscience.

2 semanas hace · 24/7 Wall St.

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)

Anthropic is racing toward a public debut in September with a healthcare AI pitch that could ignite a sector most investors are not watching. Five biotech names are already moving, and one has climbed...

2 semanas hace · Motley Fool

Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript

AI-enabled drug discovery orders drive triple-digit growth as guidance rises.

2 semanas hace · Simply Wall St.

Twist Bioscience (TWST) Is Up 26.3% After Capital Raise And Guidance Hike Amid Legal Settlement Talks - Has The Bull Case Changed?

In early August 2026, Twist Bioscience completed a US$300 million follow-on common stock offering at US$96 per share after raising its fiscal 2026 revenue guidance to US$456 million–US$457 million and...

Página 1 de 2